(Q28580820)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11683876%20AND%20SRC:MED&resulttype=core&format=json

2 December 2019

title

Characterization of indolinones which preferentially inhibit VEGF-C- and VEGF-D-induced activation of VEGFR-3 rather than VEGFR-2 (English)

2 references

31 January 2017

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11683876%20AND%20SRC:MED&resulttype=core&format=json

2 December 2019

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11683876%20AND%20SRC:MED&resulttype=core&format=json

2 December 2019

Jaya Krishnan

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11683876%20AND%20SRC:MED&resulttype=core&format=json

2 December 2019

Michael S Pepper

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11683876%20AND%20SRC:MED&resulttype=core&format=json

2 December 2019

author name string

R Mazitschek

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11683876%20AND%20SRC:MED&resulttype=core&format=json

2 December 2019

A Steffen

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11683876%20AND%20SRC:MED&resulttype=core&format=json

2 December 2019

J Waltenberger

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11683876%20AND%20SRC:MED&resulttype=core&format=json

2 December 2019

A Giannis

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11683876%20AND%20SRC:MED&resulttype=core&format=json

2 December 2019

J P Sleeman

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11683876%20AND%20SRC:MED&resulttype=core&format=json

2 December 2019

language of work or name

English

0 references

publication date

1 November 2001

2 references

31 January 2017

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11683876%20AND%20SRC:MED&resulttype=core&format=json

2 December 2019

2 references

31 January 2017

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11683876%20AND%20SRC:MED&resulttype=core&format=json

2 December 2019

volume

268

2 references

31 January 2017

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11683876%20AND%20SRC:MED&resulttype=core&format=json

2 December 2019

page(s)

5530-5540

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11683876%20AND%20SRC:MED&resulttype=core&format=json

2 December 2019

issue

21

2 references

31 January 2017

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11683876%20AND%20SRC:MED&resulttype=core&format=json

Lymphatic regeneration following microvascular limb replantation: a qualitative and quantitative animal study

2 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2001.02476.X

Signaling angiogenesis and lymphangiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2001.02476.X

Expression of the fms-like tyrosine kinase 4 gene becomes restricted to lymphatic endothelium during development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2001.02476.X

Vascular endothelial growth factor-related protein: a ligand and specific activator of the tyrosine kinase receptor Flt4

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2001.02476.X

Characterization of murine Flt4 ligand/VEGF-C

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2001.02476.X

Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4)

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2001.02476.X

Proteolytic processing regulates receptor specificity and activity of VEGF-C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2001.02476.X

Biosynthesis of vascular endothelial growth factor-D involves proteolytic processing which generates non-covalent homodimers

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2001.02476.X

Hyperplasia of lymphatic vessels in VEGF-C transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2001.02476.X

VEGF and VEGF-C: specific induction of angiogenesis and lymphangiogenesis in the differentiated avian chorioallantoic membrane

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2001.02476.X

Signalling via vascular endothelial growth factor receptor-3 is sufficient for lymphangiogenesis in transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2001.02476.X

Inhibition of lymphangiogenesis with resulting lymphedema in transgenic mice expressing soluble VEGF receptor-3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2001.02476.X

Vascular endothelial growth factor-C (VEGF-C/VEGF-2) promotes angiogenesis in the setting of tissue ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2001.02476.X

Vascular endothelial growth factor C induces angiogenesis in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2001.02476.X

Vascular endothelial growth factor (VEGF)-C synergizes with basic fibroblast growth factor and VEGF in the induction of angiogenesis in vitro and alters endothelial cell extracellular proteolytic activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2001.02476.X

c-fos-induced growth factor/vascular endothelial growth factor D induces angiogenesis in vivo and in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2001.02476.X

VEGF-D promotes the metastatic spread of tumor cells via the lymphatics

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2001.02476.X

Vascular endothelial growth factor-C-mediated lymphangiogenesis promotes tumour metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2001.02476.X

Hereditary lymphedema: evidence for linkage and genetic heterogeneity

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2001.02476.X

Congenital hereditary lymphedema caused by a mutation that inactivates VEGFR3 tyrosine kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2001.02476.X

Missense mutations interfere with VEGFR-3 signalling in primary lymphoedema

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2001.02476.X

The vascular endothelial growth factor receptor KDR activates multiple signal transduction pathways in porcine aortic endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2001.02476.X

Regulation of VEGF and VEGF receptor expression in the rodent mammary gland during pregnancy, lactation, and involution

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2001.02476.X

Single-step purification of polypeptides expressed in Escherichia coli as fusions with glutathione S-transferase

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2001.02476.X

A recombinant mutant vascular endothelial growth factor-C that has lost vascular endothelial growth factor receptor-2 binding, activation, and vascular permeability activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2001.02476.X

Structures of the tyrosine kinase domain of fibroblast growth factor receptor in complex with inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2001.02476.X

Design, synthesis, and evaluations of substituted 3-[(3- or 4-carboxyethylpyrrol-2-yl)methylidenyl]indolin-2-ones as inhibitors of VEGF, FGF, and PDGF receptor tyrosine kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2001.02476.X

Identification of a c-fos-induced gene that is related to the platelet-derived growth factor/vascular endothelial growth factor family

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2001.02476.X

Stage T1A carcinoma of prostate

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2001.02476.X

Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1432-1033.2001.02476.X

10.1046/J.1432-1033.2001.02476.X

21 January 2018

Identifiers

DOI

2 references

Consolidated OpenCitations Corpus – April 2017

3204359

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11683876%20AND%20SRC:MED&resulttype=core&format=json

2 December 2019

3204359

1 reference

Consolidated OpenCitations Corpus – April 2017

Consolidated OpenCitations Corpus – April 2017

2 references

3204359

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11683876%20AND%20SRC:MED&resulttype=core&format=json